SCHEMBL16306264

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL16306224	0.94	MME (0.46)	MMEANPEP
	SCHEMBL17834893	0.93	MME (0.41)	MMEANPEPMCL1
	SCHEMBL16306249	0.93	MME (0.41)	MMEANPEPMCL1
	SCHEMBL17834572	0.93	MME (0.46)	MMEANPEP
	SCHEMBL16305776	0.93	MME (0.42)	MMEANPEPKIFC1
	SCHEMBL17834782	0.93	MME (0.45)	MMEANPEP
	SCHEMBL17995331	0.92	MME (0.41)	MMEANPEPKIFC1
	SCHEMBL15037232	0.92	MME (0.41)	MMEANPEPMCL1KIFC1
	SCHEMBL22449273	0.92	MME (0.41)	MMEANPEPMCL1KIFC1
	SCHEMBL17834770	0.92	MME (0.41)	MMEANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.